company presentation 2015 company profile
play

COMPANY PRESENTATION 2015 Company Profile Discovery & - PowerPoint PPT Presentation

COMPANY PRESENTATION 2015 Company Profile Discovery & preclinical stage ADME-Tox CRO Founded in March 2011 Located in Oulu, Finland Serving customers from small Biotechs to Big Pharma Customers in 21 countries on 4 continents We Make a


  1. COMPANY PRESENTATION 2015

  2. Company Profile Discovery & preclinical stage ADME-Tox CRO Founded in March 2011 Located in Oulu, Finland Serving customers from small Biotechs to Big Pharma Customers in 21 countries on 4 continents

  3. We Make a Difference Specialised in drug metabolism, drug interactions, bioanalysis and pharmacokinetics 100 peer reviewed scientific papers - expertise in ADME & medical biochemistry Tailored and optimised studies - scientific & technical quality with consistency Strong expertise in analytical technologies (LC/MS and NMR) Continuous service development and adaption of customers’ processes

  4. Service Portfolio 1/2 Microsomes, S9, rec-enzymes, hepatocytes In-life part conducted with a partner • • Metabolic stability / clearance Mouse, rat, rabbit, guinea pig, pig, dog, • • Metabolite identification monkey • Extrahepatic metabolism • CYP/UGT/SULT phenotyping • Reactive metabolite screening • PBPK modeling • UPLC/MS/MS or UPLC/HR-MS CYP and UGT Inhibition, TDI/MDI/MBI • • Plasma, urine, feces, brain homogenates, CYP and UGT Induction • • Non-CYP inhibition other tissue homogenates • Method development and validation •

  5. Service Portfolio 2/2 Permeability (Caco2/MDCK) Solubility (buffer & intestinal/gastric fluids) • • P-gp or BCRP (efflux & inhibition) Lipophilicity (logD) • • Uptake transporter assays Plasma protein & brain homogenate binding & in • • vitro binding (RED) Plasma stability, chemical stability • Identification of degradation products or impurities • Cytotoxicity Metabolic stability • • Genotoxicity (AMES, MNT) CYP-inhibition screening • • Cardiotoxicity CYP-induction • • Mechanistic tox assays (oxidative stress, Permeability (Caco2) • • mitochondiral toxicity, caspase 3/7 activity)

  6. www.admescope.com CEO Ari Tolonen ari.tolonen@admescope.com

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend